EMUC26 will take place from 5–8 November 2026 in Brussels, Belgium, at The Square. As the 18th European Multidisciplinary Congress on Urological Cancers, it brings specialists together for updates, collaboration, and the latest insights in urological oncology. A solution that tackles different angles of a problem is a fortified solution. Throughout the years, multidisciplinarity has been the cornerstone of every European Multidisciplinary Congress on Urological Cancers (EMUC). At the upcoming 17th edition (EMUC25), leading experts in medical oncology, pathology, radiation oncology, radiology, nuclear medicine, and urology will examine the current practices, identify the best therapies, and review emerging innovations in genito-urinary (GU) cancers treatment and management. From 13 to 16 November 2025, you will receive essential GU cancers updates, engage in the popular hands-on training courses, and join eye-opening multidisciplinary case discussions. Dr. Elena Castro (ESMO) Dr. Alison Tree (ESTRO) Prof. Arnulf Stenzl (EAU) What are the goals for neoadjuvant chemotherapy (NAC) in renal cell carcinoma (RCC)? Prof. Jens Bedke (DE) provided important... Below you can review some of the key topics covered at the EMUC25 Congress today. We share webcasts, session... In his EMUC25 lecture ‘ctDNA in muscle-invasive bladder cancer: Ready for prime time?’ Prof. Lars Dyrskjøt (DK) shared data...Announcing EMUC26
Dear friends and colleagues,
Steering committee
Steering committee
Steering committeeWhy you should attend this congress
News and reports
Neoadjuvant treatment strategies in 2025
Highlights from Day 3
Treatment challenges in MIBC: ctDNA, EV-P cost and access
